CD8A and neoplasm: Unlike NR2F6 KO tumor-bearing mice treated with immunoglobulin G (IgG) antibodies, CD8+ T cell depletion abolished tumor growth inhibition and decreased survival of mice harboring NR2F6 KO B16F10 tumors (Fig. 3, H and I).